Skip to main content
DAIICHI SANKYO COMPANY, LIMITED logo

DAIICHI SANKYO COMPANY, LIMITED — Investor Relations & Filings

Ticker · 4568 ISIN · JP3475350009 LEI · 353800XGIU2IHQGC9504 T Manufacturing
Open in API
Filings indexed 93 across all filing types
Latest filing 2026-04-14 Transaction in Own Shar…
Country JP Japan
Listing T 4568

About DAIICHI SANKYO COMPANY, LIMITED

https://www.daiichisankyo.co.jp/

Daiichi Sankyo is an innovative global healthcare company focused on the research, development, and delivery of pharmaceutical solutions. By leveraging cutting-edge science, technology, and data analytics, the company develops novel medicines and medical treatments to address unmet needs. Its core mission is to contribute to the enrichment of quality of life for patients worldwide. The company maintains a robust R&D pipeline and actively engages in open innovation to advance its therapeutic offerings, with a significant focus on oncology and specialty medicines.

Recent filings

Filing Released Lang Actions
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document is a statutory report under the Japanese Financial Instruments and Exchange Act (Article 24-6) detailing the company’s acquisition of its own shares (quantities, dates, and amounts). This corresponds to a “Transaction in Own Shares” filing (company share repurchase activity).
2026-04-14 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document is a 'Report on Status of Acquisition of Treasury Shares' (自己株券買付状況報告書) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. It details the company's share buyback activities for the month of February 2026. According to the provided definitions, reports regarding a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2026-03-16 Japanese
訂正発行登録書
Capital/Financing Update Classification · 1% confidence The document is a '訂正発行登録書' (Amendment to Shelf Registration Statement) filed with the Kanto Local Finance Bureau by Daiichi Sankyo. It relates to the registration of corporate bonds and updates the reference documents following the submission of an extraordinary report. This type of regulatory filing regarding capital structure and financing registration falls under the 'Regulatory Filings' category as it is a specific Japanese financial disclosure document that does not fit into the other specialized categories like 10-K or CAP.
2026-03-04 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document is a '自己株券買付状況報告書' (Report on Status of Repurchase of Own Shares) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. This document specifically details the company's share buyback activities, including the number of shares acquired, disposal status, and current holdings for the reporting period of December 2025. This falls directly under the category of 'Transaction in Own Shares' (POS).
2026-01-14 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document is a '自己株券買付状況報告書' (Report on Status of Acquisition of Treasury Shares) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. This is a formal regulatory filing detailing the company's share buyback activities for a specific period. While it relates to share transactions, it is a formal regulatory disclosure of the status of treasury shares rather than a simple announcement of a transaction (POS) or a capital change (SHA). Given the specific regulatory nature of this report, it falls under the category of Transaction in Own Shares (POS) as it specifically reports the status of treasury share acquisitions.
2025-12-09 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is titled '確認書' (Confirmation Letter) and explicitly cites '金融商品取引法第24条の５の２第１項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report type, should be classified as Regulatory Filings (RNS) rather than the report itself. H1 2025
2025-11-07 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.